Quality-adjusted time without symptoms or toxicity analysis of adjuvant chemotherapy in non-small-cell lung cancer: an analysis of the National Cancer Institute of Canada Clinical Trials Group JBR.10 trial.

Jang, Raymond W

Quality-adjusted time without symptoms or toxicity analysis of adjuvant chemotherapy in non-small-cell lung cancer: an analysis of the National Cancer Institute of Canada Clinical Trials Group JBR.10 trial. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology Sep 2009 - 4268-73 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

1527-7755

10.1200/JCO.2008.20.5815 doi


Antineoplastic Combined Chemotherapy Protocols--adverse effects
Canada
Carcinoma, Non-Small-Cell Lung--drug therapy
Chemotherapy, Adjuvant
Cisplatin--administration & dosage
Humans
Lung Neoplasms--drug therapy
Outcome Assessment, Health Care--methods
Prospective Studies
Quality of Life
Randomized Controlled Trials as Topic
Surveys and Questionnaires
Survival Analysis
Vinblastine--administration & dosage
Vinorelbine